Persistence Market Research, a leading management consulting firm, has released this update on the gene editing market. Gene editing technologies enable precise modification of DNA, transforming ...
Ajay Gannerkote, president of Integrated DNA Technologies (IDT), says what’s most exciting about CRISPR is its potential to shift medicine from managing disease to directly correcting its root cause. ...
It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...
Revolutions in gene therapy are rapidly changing the landscape of modern medicine. Revolutions in gene therapy are rapidly changing the landscape of modern medicine, forcing society and science alike ...
Emerging gene-editing platforms are demonstrating that disease-causing mutations, aberrant gene expression, and even large-scale DNA insertions can be corrected without relying on error-prone DNA ...
Faulty versions of the LMNA gene can cause a wide range of health problems, including heart muscle disease (dilated cardiomyopathy) and muscle weakness (muscular dystrophies). Many of these diseases ...
A single infusion of a gene-editing therapy cut LDL cholesterol by roughly half in patients with inherited high cholesterol ...
Enhancers are pieces of DNA that act like switches, regulating when genes are turned on and off and how strongly they are ...
A 3D illustration of a transfer RNA molecule hovering over a messenger RNA. Transfer RNA acts as an adaptor to convert messenger RNA codons into amino acids during protein synthesis. Credit: ...
The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not without risk. When this type of "genetic surgery" is performed on DNA, for ...
Secreting proteins from cells into surrounding tissue, or into circulation, opens new treatment opportunities beyond ...
Discover the top gene editing stocks to watch. Learn about this groundbreaking field and the companies leading advancements in genetic science.